Mei‐Dong Xu
Mei‐Dong Xu publishes mostly in Surgery, Pulmonary and Respiratory Medicine and Gastroenterology, on topics such as Gastrointestinal Tumor Research and Treatment, Gastric Cancer Management and Outcomes and Gastrointestinal disorders and treatments.
- World rank
- #524,475 of 7,710,434 ranked researchers
- Rank in China
- #65,318 of 978,568
- Works
- 207
- Citations
- 4.8k
- Citations per work
- 23.4
What does Mei‐Dong Xu research?
Mei‐Dong Xu's work is mostly in Medicine (74%), Biochemistry, Genetics and Molecular Biology (6%), Health Professions (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences15976.7%
- Medicine15273.5%
- Health Professions73.2%
- Everything else3717.7%
- Life Sciences125.6%
- 1Surgery25% of their works
- 2Pulmonary and Respiratory Medicine23% of their works
- 3Gastroenterology22% of their works
- 4Molecular Biology6% of their works
- 5Speech and Hearing3% of their works
- 6Oncology3% of their works
Research topics
- Gastrointestinal Tumor Research and Treatment
- Gastric Cancer Management and Outcomes
- Gastrointestinal disorders and treatments
- Esophageal Cancer Research and Treatment
- Metastasis and carcinoma case studies
- Esophageal and GI Pathology
- Gastroesophageal reflux and treatments
- Dysphagia Assessment and Management
Which keywords describe Mei‐Dong Xu's research?
The keywords of their largest research topics: Endoscopic Resection, Epidemiology, Imatinib Mesylate, Sunitinib, Chemotherapy, Gastric Cancer, Complications and Intussusception.
- Dysphagia
- Esophageal Motility Disorders
- Endoscopic Stenting
- Lung Tumors
- Esophageal Carcinoma
- Intussusception
- Gastric Cancer
- Sunitinib
- Epidemiology
- Endoscopic Resection
- Imatinib Mesylate
- Chemotherapy
- Complications
- Meckel's Diverticulum
- Preoperative Chemoradiotherapy
- Metastatic Carcinomas
- Esophageal Perforation
- Gastroesophageal Reflux Disease
- Swallowing
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Endoscopic Resection1302 topics
- Epidemiology1113 topics
- Imatinib Mesylate921 topic
- Sunitinib921 topic
- Chemotherapy911 topic
- Gastric Cancer911 topic
- Complications722 topics
- Intussusception471 topic
- Meckel's Diverticulum471 topic
- Esophageal Carcinoma391 topic
- Preoperative Chemoradiotherapy391 topic
- Lung Tumors371 topic
- Metastatic Carcinomas371 topic
- Endoscopic Stenting261 topic
- Esophageal Perforation261 topic
- Esophageal Motility Disorders251 topic
- Gastroesophageal Reflux Disease251 topic
- Dysphagia191 topic
- Swallowing191 topic
Where does Mei‐Dong Xu work?
Mei‐Dong Xu's main affiliation in the publication record is Fudan University, China.
How many publications and citations does Mei‐Dong Xu have?
OpenAlex counts 207 works and 4,835 citations for Mei‐Dong Xu, an h-index of 36, ranking #524,475 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Mei‐Dong Xu
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mei‐Dong Xu. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.